GL1X · GenesisL1 explorer

Research workbench

Structural basis for CSPG4 as a receptor for tcdb and a therapeutic target in clostridioides difficile infection

Analyse Structural basis for CSPG4 as a receptor for tcdb and a therapeutic target in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7ML7
Type
protein
Length
1,354 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Toxin B; Chondroitin sulfate proteoglycan 4
EC
3.4.22.-
UniProt
P18177, Q6UVK1
Ligands
ZN
Pockets
16 · best druggability 0.84

Structure

electron microscopy · 2 distinct chains · 34% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AToxin B (EC 3.4.22.-)protein121637% helix, 18% strandP18177
BChondroitin sulfate proteoglycan 4protein13811% helix, 30% strandQ6UVK1

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111590.840.85145empty
26290.800.8584empty
37100.780.8262empty
42200.700.8723empty
53620.650.8053empty

Interfaces

1 interface between chains.

  • A–B · 1425 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 7ML7 · Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q6UVK1 · AlphaFold monomer V2.0 prediction for chondroitin sulfate proteoglycan 4 (Q6UVK1) · a predicted model of the same protein · chain B against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.